BioNTech SE Current Provisions
BioNTech SE (BNTX) had Current Provisions of EUR 145.30 million as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:CurrentProvisions · last filed 2026-03-10
- 2025-12-31: Current Provisions 145.30M EUR.
- 2024-12-31: Current Provisions 144.80M EUR.
- 2023-12-31: Current Provisions 269.30M EUR.
- 2022-12-31: Current Provisions 367.20M EUR.
| Period end | Current Provisions |
|---|---|
| 2025-12-31 | 145.30M EUR 20-F · filed 2026-03-10 |
| 2024-12-31 | 144.80M EUR 20-F · filed 2026-03-10 |
| 2023-12-31 | 269.30M EUR 20-F · filed 2025-03-10 |
| 2022-12-31 | 367.20M EUR 20-F · filed 2024-03-20 |
| 2021-12-31 | 110.20M EUR 20-F · filed 2023-03-27 |
| 2020-12-31 | 900.00K EUR 20-F/A · filed 2022-10-26 |
| 2019-12-31 | 762.00K EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 710.00K EUR 20-F · filed 2020-03-31 |